Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for AC Immune (ACIU) over the last 9 years, with Q3 2025 value amounting to -$1.5 million.

  • AC Immune's Change in Account Payables fell 654086.02% to -$1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $289894.8, marking a year-over-year increase of 162651.31%. This contributed to the annual value of $1.1 million for FY2024, which is 2847.76% up from last year.
  • AC Immune's Change in Account Payables amounted to -$1.5 million in Q3 2025, which was down 654086.02% from $748892.0 recorded in Q2 2025.
  • AC Immune's 5-year Change in Account Payables high stood at $2.0 million for Q4 2021, and its period low was -$2.0 million during Q1 2021.
  • Its 5-year average for Change in Account Payables is -$21925.0, with a median of -$21929.9 in 2024.
  • As far as peak fluctuations go, AC Immune's Change in Account Payables skyrocketed by 167845.53% in 2022, and later tumbled by 654086.02% in 2025.
  • Over the past 5 years, AC Immune's Change in Account Payables (Quarter) stood at $2.0 million in 2021, then plummeted by 137.01% to -$727653.2 in 2022, then surged by 131.45% to $228853.0 in 2023, then skyrocketed by 519.51% to $1.4 million in 2024, then tumbled by 202.72% to -$1.5 million in 2025.
  • Its Change in Account Payables stands at -$1.5 million for Q3 2025, versus $748892.0 for Q2 2025 and -$420430.7 for Q1 2025.